MENU
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Viridian Therapeutics (VRDN) Ownership - Who owns Viridian Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.78B
P/E Ratio
N/A
Total Cash
10.45M
Projected Growth
N/A
Total Debt
21.06M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.14
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
VRDN
Capitalization
1.78B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
10.4M
Total Cash/Share
0.14
Total Debt
21.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
N/A
ROE
N/A
Book Value
383M
P/B Ratio
5.41
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
638K
Current Ratio
23.99
Current Revenue Per Employee
765.96
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
8.47
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
76.4M
Total Liabilities
47.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-33.563
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com